Mast cells and vasculature in atopic dermatitis--potential stimulus of neoangiogenesis.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 15575937)

Published in Allergy on January 01, 2005

Authors

D A Groneberg1, C Bester, A Grützkau, F Serowka, A Fischer, B M Henz, P Welker

Author Affiliations

1: Department of Pediatric Pneumology and Immunology, Division of Allergy Research, Charité School of Medicine, Free University and Humboldt University, Berlin, Germany.

Articles citing this

Tobacco smoke particles and indoor air quality (ToPIQ) - the protocol of a new study. J Occup Med Toxicol (2011) 0.93

Increased plasma concentration of vascular endothelial growth factor in patients with atopic dermatitis and its relation to disease severity and platelet activation. Inflamm Res (2012) 0.86

Mobile air quality studies (MAQS) in inner cities: particulate matter PM10 levels related to different vehicle driving modes and integration of data into a geographical information program. J Occup Med Toxicol (2012) 0.85

Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats. J Cell Mol Med (2008) 0.84

Evaluation of adipokines: apelin, visfatin, and resistin in children with atopic dermatitis. Mediators Inflamm (2013) 0.82

Neurotensin and CRH interactions augment human mast cell activation. PLoS One (2012) 0.82

High abundances of neurotrophin 3 in atopic dermatitis mast cell. J Occup Med Toxicol (2009) 0.80

Car indoor air pollution - analysis of potential sources. J Occup Med Toxicol (2011) 0.79

Serum concentrations of metalloproteinase 2, metalloproteinase 9 and granzyme B in contact eczema patients. Postepy Dermatol Alergol (2013) 0.78

Anti-inflammatory effect of qingpeng ointment in atopic dermatitis-like murine model. Evid Based Complement Alternat Med (2013) 0.78

Nanoparticles and cars - analysis of potential sources. J Occup Med Toxicol (2012) 0.75

Molecular Genetic of Atopic dermatitis: An Update. Int J Health Sci (Qassim) (2016) 0.75

Articles by these authors

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (2003) 19.77

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (1996) 11.13

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science (2000) 10.40

Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell (2000) 9.99

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med (2011) 7.89

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med (1996) 5.36

Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet (2000) 5.11

Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A (1995) 5.06

Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science (1999) 4.93

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science (1995) 4.80

Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell (2001) 4.79

Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science (1998) 4.58

CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature (1993) 4.11

X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86

Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr (1997) 3.63

CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci U S A (2001) 3.54

Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res (1995) 3.33

A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet (1999) 3.12

Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet (1989) 2.98

The diagnosis and management of chronic cough. Eur Respir J (2004) 2.96

Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet (1997) 2.93

The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J Biol Chem (1994) 2.92

Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci U S A (1995) 2.89

Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest (1997) 2.76

The Arabidopsis thaliana genome contains at least 29 active genes encoding SET domain proteins that can be assigned to four evolutionarily conserved classes. Nucleic Acids Res (2001) 2.70

Attitudes and knowledge relevant to family planning among New Orleans Negro women. Am J Public Health Nations Health (1966) 2.60

Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest (1990) 2.46

Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics (1994) 2.33

Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. Lancet (1984) 2.32

Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest (1998) 2.30

Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell (1998) 2.24

Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr (1989) 2.22

Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia (1996) 2.15

Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study. Pediatrics (1996) 2.14

Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol (2000) 2.13

Immunological conditions of children with BCG disseminated infection. Lancet (1995) 2.05

Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med (2001) 2.05

Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis. J Clin Invest (1978) 2.03

Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet (2000) 1.98

Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis (1997) 1.96

Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther (2001) 1.95

Wnt-1 regulation of connexin43 in cardiac myocytes. J Clin Invest (2000) 1.87

Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut (2007) 1.85

The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clin Exp Immunol (2009) 1.81

Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr (1993) 1.81

CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis. Neurology (2012) 1.80

The sensory and sympathetic innervation of guinea-pig lung and trachea as studied by retrograde neuronal tracing and double-labelling immunohistochemistry. Neuroscience (1992) 1.78

Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients. Clin Exp Allergy (2005) 1.76

The mitosome, a novel organelle related to mitochondria in the amitochondrial parasite Entamoeba histolytica. Mol Microbiol (1999) 1.75

An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. Hum Mol Genet (1993) 1.75

Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr (1999) 1.73

Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med (1996) 1.73

Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant (2007) 1.72

Extracorporeal shock wave therapy of nonunion or delayed osseous union. Clin Orthop Relat Res (2001) 1.67

Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. Blood (2001) 1.65

Conditional lineage ablation to model human diseases. Proc Natl Acad Sci U S A (1998) 1.64

Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. Am J Physiol Gastrointest Liver Physiol (2001) 1.62

Perioperative management of patients with cardiac implantable electronic devices. Br J Anaesth (2011) 1.61

Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. N Engl J Med (1997) 1.60

Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome. J Cell Biol (1998) 1.60

Graphitic tribological layers in metal-on-metal hip replacements. Science (2011) 1.60

The production, storage and release of the neurotrophins nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 by human peripheral eosinophils in allergics and non-allergics. Clin Exp Allergy (2003) 1.59

C3a and C5a stimulate chemotaxis of human mast cells. Blood (1997) 1.55

EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy (2006) 1.55

Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity. J Immunol (1981) 1.55

Two genes are responsible for Griscelli syndrome at the same 15q21 locus. Genomics (2000) 1.54

Treatment of childhood autoimmune haemolytic anaemia with rituximab. Lancet (2001) 1.54

Oscillating expression of c-Hey2 in the presomitic mesoderm suggests that the segmentation clock may use combinatorial signaling through multiple interacting bHLH factors. Dev Biol (2000) 1.53

The complex evolutionary history of gorillas: insights from genomic data. Mol Biol Evol (2006) 1.52

Defect in IgV gene somatic hypermutation in common variable immuno-deficiency syndrome. Proc Natl Acad Sci U S A (1998) 1.51

The chronically symptomatic vulva: aetiology and management. Br J Obstet Gynaecol (1995) 1.50

Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood (1997) 1.49

Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ (2003) 1.48

A primary T-cell immunodeficiency associated with defective transmembrane calcium influx. Blood (1995) 1.48

Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J Immunol (2000) 1.47

Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J Pathol (1997) 1.47

MIXED CULTURES OF PURE STRAINS OF FIBROBLASTS AND EPITHELIAL CELLS. J Exp Med (1922) 1.47

Activation of the specific neurotrophin receptors TrkA, TrkB and TrkC influences the function of eosinophils. Clin Exp Allergy (2002) 1.47

Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int (1992) 1.46

Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation (1988) 1.45

Current controversies in colorectal surgery: the way to resolve uncertainty and move forward. Colorectal Dis (2012) 1.45

The interaction between Cdc42 and WASP is required for SDF-1-induced T-lymphocyte chemotaxis. Blood (2001) 1.44

Is a single oral dose of ivermectin sufficient in crusted scabies? Int J Dermatol (2001) 1.44

Human mast cells produce IL-8. J Immunol (1993) 1.44

Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr (1993) 1.43

Severe aplastic anemia of neonatal onset: a single-center retrospective study of six children. J Pediatr (1998) 1.43

Factor VII and activated-factor-VII content of prothrombin complex concentrates. The PCC Study Group. Vox Sang (1997) 1.43

Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes. Eur J Immunol (1993) 1.42

Partial albinism with immunodeficiency (Griscelli syndrome). J Pediatr (1994) 1.42

Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma. J Pathol (1999) 1.40

Impact of the implantable cardioverter-defibrillator on rehospitalizations. Eur Heart J (1996) 1.40

Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood (1998) 1.39

[Model trial: use and evaluation of a problem-oriented learning program in internal medicine]. Med Klin (Munich) (1999) 1.39

Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections. J Infect Dis (1993) 1.39

Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation. Bone Marrow Transplant (1994) 1.38

[Urticaria pigmentosa and mastocytosis]. Dtsch Med Wochenschr (1998) 1.38

Abnormal methylation pattern in constitutive and facultative (X inactive chromosome) heterochromatin of ICF patients. Hum Mol Genet (1994) 1.38

[Modifying therapeutic in immune response]. Arch Fr Pediatr (1992) 1.38

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations. Blood (1999) 1.38